1. Rice J., Saccone N., Rasmussen E. Definition of the phenotype. Adv. Genet. 2001; 42: 69–76.

2. Авдеев С.Н. Фенотипы хронической обструктивной болезни легких: особенности терапии. Consilium Medicum: Бол. органов дыхания: 2010; прил. 23–28.

3. Kreider M., Christie J., Thompson B. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005; 128: 207–215.

4. Judson M. Comparison of sarcoidosis phenotypes among affected AfricanAmerican siblings. Chest 2006; 130: 855–862.

5. Rossman M., Thompson B., Frederick M.: HLADRB1*1101: A significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 2003; 73: 720–735.

6. Pabst S., Fränken T., Schönau J. et al. Transforming growth factorβ gene polymorphisms in different phenotypes of sarcoidosis. Eur. Respir. J. 2011; 38: 169.

7. Hiroe S., Felix A., Tarig A. et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Chest 2005; 128: 207–215.

8. Rodrigues S., Rocha N., Lima M. et al. Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil. Sarcoidos. Vasc. Diffuse Lung Dis. 2011; 28: 34–43.